Truist Securities Downgrades Alnylam Pharmaceuticals (ALNY) to Hold Nov 2, 2026 05:07AM
Alnylam Pharmaceuticals (ALNY) PT Lowered to $350 at Freedom Broker Oct 30, 2026 12:26PM
Alnylam Pharmaceuticals (ALNY) PT Lowered to $329 at UBS Oct 30, 2026 10:13AM
Bernstein SocGen Group Downgrades Alnylam Pharmaceuticals (ALNY) to Market Perform Oct 30, 2026 08:45AM
Alnylam Pharmaceuticals (ALNY) PT Lowered to $290 at BMO Capital Oct 30, 2026 04:50AM
View Older Stories

Oct 30, 2026 04:45AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $287 at BofA Securities
Oct 30, 2026 03:48AM Raymond James Downgrades Alnylam Pharmaceuticals (ALNY) to Outperform
Oct 29, 2026 10:30AM Stifel Downgrades Alnylam Pharmaceuticals (ALNY) to Hold
Oct 29, 2026 08:20AM Alnylam Pharma (ALNY) reported Q3 result ; Offers Guidance
Oct 28, 2026 07:27AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 23, 2026 12:41PM Raymond James Reiterates Strong Buy Rating on Alnylam Pharmaceuticals (ALNY)
Oct 16, 2026 06:23AM Jefferies Highlights Top Mid-Cap Biotech Stocks Ahead of Earnings
Oct 12, 2026 09:04AM Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
Sep 30, 2026 06:58AM Alnylam Pharmaceuticals (ALNY) Reiterated at Neutral by Cantor Fitzgerald Amid Exciting Pipeline Inbounds
Sep 21, 2026 07:29AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 21, 2026 07:29AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 21, 2026 06:56AM Truist Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 2, 2026 06:54AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Sep 1, 2026 09:07AM Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
Aug 31, 2026 09:20AM Stifel Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Aug 31, 2026 09:05AM Truist Securities Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Aug 31, 2026 09:03AM TD Cowen Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Aug 31, 2026 08:57AM BMO Capital on Alnylam Pharmaceuticals (ALNY): 'Strong ATTR Outlook With Limited Readthrough From Eplontersen'
Aug 31, 2026 07:10AM Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Aug 31, 2026 06:04AM Alnylam presents vutrisiran and zilebesiran data at ESC 2026
Aug 25, 2026 03:31AM Bernstein SocGen Group Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)
Aug 19, 2026 05:29AM BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
Aug 3, 2026 07:20AM Raymond James Upgrades Alnylam Pharmaceuticals (ALNY) to Strong Buy
Jul 31, 2026 10:04AM Alnylam Pharma. (ALNY) PT Lowered; RBC Capital: 'Tough Update But Stock Reaction Looks Overdone'
Jul 31, 2026 06:41AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jul 30, 2026 08:09AM Alnylam Pharma (ALNY) Tops Q2 EPS by 24c ; Offers Guidance
Jul 15, 2026 05:50AM Alnylam advances Alzheimer's drug trials, reports mivelsiran safety data
Jul 14, 2026 07:29AM Alnylam Pharmaceuticals (ALNY) Reiterated at Buy by Stifel Post CARDIO-TTRansform Failure
Jul 14, 2026 06:55AM Alnylam Pharmaceuticals (ALNY) PT Raised to $485 at H.C. Wainwright
Jul 14, 2026 06:02AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at BofA Securities
Jul 13, 2026 07:40AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at Truist Securities
Jul 9, 2026 10:33AM Increasing unusual call volume: ACI LEVI IHI FE KHC BBIO IONS OCUL XME DOMO ALNY
Jul 9, 2026 06:16AM Stifel: 'We expect IONS shares to trade lower today and ALNY shares to be volatile'
Jun 30, 2026 06:51AM Canaccord Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jun 29, 2026 07:07AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $470 at H.C. Wainwright
Jun 10, 2026 07:47AM GENESIS Pharma expands Alnylam partnership to Nordic markets
Jun 5, 2026 08:17AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Jun 3, 2026 04:45PM Alnylam partners with Inceptive in $2B AI collaboration for drug discovery
May 12, 2026 05:27AM Alnylam presents vutrisiran data showing benefits across ATTR-CM patients
May 5, 2026 07:29AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
May 1, 2026 09:52AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $447 at Bernstein SocGen Group
Apr 30, 2026 08:02AM Alnylam Pharma (ALNY) Tops Q1 EPS by 108c, provides guidance
Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews
Apr 24, 2026 08:34AM Alnylam Pharmaceuticals (ALNY) PT Lowered to $448 at Bernstein SocGen
Mar 30, 2026 01:00PM Alnylam presents cardiovascular drug data at medical conference
Mar 26, 2026 06:40AM H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Mar 25, 2026 11:39AM Stifel on Alnylam Pharmaceuticals (ALNY): 'positively biased after the pullback'
Mar 24, 2026 03:10PM BofA on Alnylam (ALNY): 'AI-enabled diagnostics will help increase diagnosis rates'
Mar 24, 2026 03:08PM Morgan Stanley: 'we see Amvuttra as well positioned'
Mar 24, 2026 07:30AM Alnylam partners with Viz.ai and American Heart Association on ATTR-CM care
View Older Stories